Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Cytosorbents Crp stock

Learn how to easily invest in Cytosorbents Crp stock.

Cytosorbents Crp is a medical devices business based in the US. Cytosorbents Crp shares (CTSO) are listed on the NASDAQ and all prices are listed in US Dollars. Cytosorbents Crp employs 221 staff and has a trailing 12-month revenue of around $36.1 million.

How to buy Cytosorbents Crp stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – CTSO. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Cytosorbents Crp stock price (NASDAQ: CTSO)

Use our graph to track the performance of CTSO stocks over time.

Cytosorbents Crp shares at a glance

Information last updated 2023-01-24.
Latest market close$2.37
52-week range$1.03 - $4.15
50-day moving average $1.54
200-day moving average $1.90
Wall St. target price$9.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.68

Buy Cytosorbents Crp stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Cytosorbents Crp stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cytosorbents Crp price performance over time

Historical closes compared with the close of $2.37 from 2023-01-27

1 week (2023-01-23) 10.75%
1 month (2022-12-30) 52.90%
3 months (2022-10-28) 36.21%
6 months (2022-07-29) 3.95%
1 year (2022-01-28) -32.09%
2 years (2021-01-29) -77.41%
3 years (2020-01-30) 4.96
5 years (2018-01-30) 7.6

Cytosorbents Crp financials

Revenue TTM $36.1 million
Gross profit TTM $32.5 million
Return on assets TTM -26.97%
Return on equity TTM -75.36%
Profit margin -114.61%
Book value $0.90
Market capitalisation $101.7 million

TTM: trailing 12 months

Cytosorbents Crp share dividends

We're not expecting Cytosorbents Crp to pay a dividend over the next 12 months.

Have Cytosorbents Crp's shares ever split?

Cytosorbents Crp's shares were split on a 1:25 basis on 4 December 2014. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cytosorbents Crp shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Cytosorbents Crp shares which in turn could have impacted Cytosorbents Crp's share price.

Cytosorbents Crp share price volatility

Over the last 12 months, Cytosorbents Crp's shares have ranged in value from as little as $1.03 up to $4.15. A popular way to gauge a stock's volatility is its "beta".

CTSO.US volatility(beta: 0.51)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cytosorbents Crp's is 0.5051. This would suggest that Cytosorbents Crp's shares are less volatile than average (for this exchange).

Cytosorbents Crp overview

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of perioperative complications of cardiopulmonary bypass surgery, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant. The company also develops VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals; CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, as well as removal of anti-A and anti-B blood group antibodies from fresh whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it is involved in the development of BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove toxic chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey. .

Frequently asked questions

What percentage of Cytosorbents Crp is owned by insiders or institutions?
Currently 9.859% of Cytosorbents Crp shares are held by insiders and 38.254% by institutions.
How many people work for Cytosorbents Crp?
Latest data suggests 221 work at Cytosorbents Crp.
When does the fiscal year end for Cytosorbents Crp?
Cytosorbents Crp's fiscal year ends in December.
Where is Cytosorbents Crp based?
Cytosorbents Crp's address is: 305 College Road East, Princeton, NJ, United States, 08540
What is Cytosorbents Crp's ISIN number?
Cytosorbents Crp's international securities identification number is: US23283X2062
What is Cytosorbents Crp's CUSIP number?
Cytosorbents Crp's Committee on Uniform Securities Identification Procedures number is: 58404X107

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site